Pharnext (OTCMKTS:PNEXF) Shares Scheduled to Reverse Split on Thursday, February 15th

Pharnext SA (OTCMKTS:PNEXFFree Report)’s stock is set to reverse split on Thursday, February 15th. The 1-10000 reverse split was announced on Thursday, February 15th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, February 15th.

Pharnext Price Performance

Shares of Pharnext stock opened at $400.00 on Tuesday. Pharnext has a 1 year low of $0.00 and a 1 year high of $0.00. The company’s fifty day moving average is $400.00 and its two-hundred day moving average is $507,340.85.

Pharnext Company Profile

(Get Free Report)

Pharnext SA, a clinical-stage biopharmaceutical company, engages in the development of therapies for neurodegenerative diseases with high unmet medical needs. Its products include PXT3003, a novel fixed-dose synergistic combination of baclofen, naltrexone, and sorbitol formulated that is in Phase III clinical trials for the treatment of Charcot-Marie-tooth disease type 1A; and PXT864 to treat amyotrophic lateral sclerosis.

Featured Articles

Receive News & Ratings for Pharnext Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharnext and related companies with MarketBeat.com's FREE daily email newsletter.